Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Neoleukin Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

firstwordpharmaDecember 22, 2019

Tag: BofA Securities , Neoleukin Therapeutics , Purchase Additional Shares

PharmaSources Customer Service